🇺🇸 FDA
Patent

US 6045802

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

expired A61KA61K2239/31A61K2239/38

Quick answer

US patent 6045802 (Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K39/00, A61K40/11